Related Experiment Videos
Nicotine alters catecholamines and electrocortical activity in perfused mouse brain
Pharmacology, Biochemistry, and Behavior
|January 1, 1986
Summary
Nicotine affects brain activity and catecholamine metabolism differently in mouse strains. These findings highlight strain-specific responses to nicotine, impacting electrocortical (ECoG) activity and neurotransmitter levels.
Area of Science:
- Neuroscience
- Pharmacology
- Biochemistry
Background:
- Mice strains C3H and C57BL exhibit distinct behavioral responses to nicotine.
- Nicotine's impact on brain activity and neurotransmitter metabolism is not fully understood across different genetic backgrounds.
Purpose of the Study:
- To investigate the differential effects of nicotine on electrocortical (ECoG) activity and catecholamine metabolism in C3H and C57BL mice.
- To correlate nicotine-induced neurophysiological changes with alterations in brain neurotransmitter levels.
Main Methods:
- Utilized isolated perfused mouse brain (IPMB) models for both C3H and C57BL strains.
- Measured electrocortical (ECoG) activity and quantified catecholamine metabolites, including homovanillic acid (HVA) and 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
- Assessed brain tissue levels of norepinephrine and dopamine.
Main Results:
- In C3H mice, nicotine caused concentration-dependent ECoG desynchronization with unchanged homovanillic acid (HVA) production and a reduction in 3-methoxy-4-hydroxyphenethyleneglycol (MHPG).
- In C57BL mice, nicotine enhanced ECoG amplitude, decreased HVA production, showed a trend of reduced MHPG, and was associated with increased norepinephrine and dopamine levels.
- Brain catecholamine content remained relatively stable in C3H mice but increased in C57BL mice.
Conclusions:
- Nicotine differentially alters electrocortical activity and catecholamine metabolism based on mouse strain.
- The observed neurochemical changes in C57BL mice align with their known behavioral sensitivity to nicotine.
- These findings underscore the importance of genetic background in mediating nicotine's central nervous system effects.